A growing crisis is unfolding in Zimbabwe as some nurses at public clinics in Harare are reportedly charging people living with HIV illicit fees for access to ...

Critical community initiatives that provide testing, food and support and HIV vaccine research have been dismantled.

This was before generic HIV medication, which is cheaper, became available.“But now we even have injectable ARVs that cost as much as Sh4 million,” she observes.In 2022, the first patient in ...

Arvinas, Inc., a biotechnology company focused on targeted protein degradation therapies, announced that new preclinical data for its investigational drug ARV-393 will be presented at the upcoming ...

Arvinas, Inc. announced promising preclinical results for ARV-393, a targeted protein degrader aimed at treating non-Hodgkin lymphoma, particularly high grade B-cell lymphomas. Data showed that ...

The Government of Ukraine, in consultation with partners, is exploring the use of unspent budget lines and Global Fund reprogramming to cover immediate gaps.

Company to highlight preclinical study of ARV-393, an investigational PROTAC BCL6 degrader, in combination with standard of care therapies NEW HAVEN, Conn., April 21, 2025 (GLOBE NEWSWIRE) -- Arvinas, ...